🔗 Share this article

Chancellor Rachel Reeves has revealed she is planning "specific steps to tackle household expense pressures" in next month's financial statement.

During an interview with media outlets, she emphasized that reducing price rises is a collective responsibility of both the administration and the Bank of England.

The United Kingdom's price growth is expected to be the highest among the G7 developed nations this calendar year and next.

Potential Energy Bill Measures

Sources suggest the administration could intervene to lower energy bills, for example by cutting the current 5% level of value-added tax applied on energy.

An additional option is to reduce some of the government charges currently included in bills.

Fiscal Constraints and Analyst Expectations

The administration will obtain the next report from the official forecaster, the OBR, on the start of the week, which will reveal how much room there is for such measures.

The view from most economists is that Reeves will have to announce higher taxes or budget cuts in order to meet her voluntary borrowing rules.

Previously on the same day, analysis indicated there was a twenty-two billion pound gap for the Treasury chief to address, which is at the more modest range of forecasts.

"It is a shared job between the Bank of England and the government to continue tackling some of the causes of price increases," the Chancellor stated to reporters in the US capital, at the yearly gatherings of the IMF and global financial institution.

Tax Pledges and Global Issues

While much of the attention has been on probable tax rises, the chancellor said the latest data from the fiscal watchdog had not altered her commitment to campaign commitments not to raise tax levels on earnings tax, VAT or social security contributions.

She attributed an "unpredictable world" with increasing geopolitical and commercial concerns for the fiscal revenue measures, likely to be targeted on those "with the broadest shoulders."

International Economic Disputes

Commenting on concerns about the United Kingdom's trade ties with the Asian nation she said: "Our security interests invariably are paramount."

Last week's announcement by China to tighten export controls on rare earths and other resources that are key for advanced tech manufacturing led US President the US President to propose an additional 100% import tax on imports from China, raising the possibility of an full-scale commercial conflict between the two economic giants.

The US Treasury Secretary described the Chinese move "economic coercion" and "a global supply chain power grab."

Questioned on considering the US offer to participate in its conflict with China, Reeves said she was "very concerned" by Chinese actions and urged the Chinese government "to avoid restrictions and restrict access."

She said the decision was "damaging for the international commerce and generates further obstacles."

"It is my opinion there are sectors where we need to challenge China, but there are also important prospects to export to Chinese markets, including financial services and other sectors of the economic system. We've got to get that equilibrium appropriate."

The chancellor also affirmed she was working with international partners "regarding our own critical minerals strategy, so that we are more independent."

NHS Drug Costs and Investment

Reeves also recognized that the cost the National Health Service pays for medicines could rise as a result of current discussions with the Trump administration and its drugs companies, in return for lower tariffs and capital.

Some of the biggest global pharmaceutical manufacturers have said lately that they are either halting or abandoning operations in the UK, with several blaming the insufficient payments they are getting.

Last month, the Science Minister said the cost the health service pays for drugs would need to rise to stop firms and drug research funding leaving the UK.

The Chancellor informed the BBC: "It has been observed as a result of the payment system, that drug testing, recent pharmaceuticals have not been offered in the UK in the way that they are in other EU nations."

"We want to ensure that people getting care from the National Health Service are able to obtain the top essential treatments in the globe. And so we are looking at these issues, and... aiming to secure increased investment into the UK."